Barinthus Biotherapeutics earnings were -$57.8M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest BRNS earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$8.1M, down 52.1% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, BRNS reported annual earnings of -$73.3M, with -1,473% growth. The next BRNS earnings date is Mar 18, 2025.
Barinthus Biotherapeutics Earnings Reports & History FAQ
What were Barinthus Biotherapeutics's earnings last quarter?
On BRNS's earnings call on Invalid Date, Barinthus Biotherapeutics (NASDAQ: BRNS) reported Q3 2024 earnings per share (EPS) of -$0.21, up 43.24% year over year. Total BRNS earnings for the quarter were -$8.11 million. In the same quarter last year, Barinthus Biotherapeutics's earnings per share (EPS) was -$0.37.
When does Barinthus Biotherapeutics report earnings?
The next BRNS earnings date is Invalid Date. Add BRNS to your watchlist to be reminded of Barinthus Biotherapeutics's next earnings date.
What was BRNS's earnings growth in the past year?
As of Barinthus Biotherapeutics's earnings date in Invalid Date, Barinthus Biotherapeutics's earnings has grown year over year. BRNS earnings in the past year totalled -$57.83 million.
Is Barinthus Biotherapeutics profitable or losing money?
As of the last Barinthus Biotherapeutics earnings report, Barinthus Biotherapeutics is currently losing money. Barinthus Biotherapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$57.83 million, a 25.14% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.